Javier Cano

Esteve Healthcare SL is a Spanish international specialty pharma company that has experienced significant growth in 2022, expanding its presence in Europe and beyond. Esteve Healthcare is based in Barcelona, ES, and has subsidiaries in Germany. The company has launched an inhaled treatment for off periods in Parkinson's disease and is collaborating with Medtronic to improve the pathway of patients with refractory cancer pain. The company was founded in 1929 by Antoni Esteve Subirana, and Staffan Schüberg has been the CEO of the company since 2019.

Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain.

Esteve Healthcare SL is a Spanish international specialty pharma company that has experienced significant growth in 2022, expanding its presence in Europe and beyond. Esteve Healthcare is based in Barcelona, ES, and has subsidiaries in Germany. The company has launched an inhaled treatment for off periods in Parkinson's disease and is collaborating with Medtronic to improve the pathway of patients with refractory cancer pain. The company was founded in 1929 by Antoni Esteve Subirana, and Staffan Schüberg has been the CEO of the company since 2019.

Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain.

Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain.

Esteve Healthcare SL is a Spanish international specialty pharma company that has experienced significant growth in 2022, expanding its presence in Europe and beyond. Esteve Healthcare is based in Barcelona, ES, and has subsidiaries in Germany. The company has launched an inhaled treatment for off periods in Parkinson's disease and is collaborating with Medtronic to improve the pathway of patients with refractory cancer pain. The company was founded in 1929 by Antoni Esteve Subirana, and Staffan Schüberg has been the CEO of the company since 2019.

Esteve Healthcare SL is a Spanish international specialty pharma company that has experienced significant growth in 2022, expanding its presence in Europe and beyond. Esteve Healthcare is based in Barcelona, ES, and has subsidiaries in Germany. The company has launched an inhaled treatment for off periods in Parkinson's disease and is collaborating with Medtronic to improve the pathway of patients with refractory cancer pain. The company was founded in 1929 by Antoni Esteve Subirana, and Staffan Schüberg has been the CEO of the company since 2019.

Esteve Healthcare SL is a Spanish international specialty pharma company that has experienced significant growth in 2022, expanding its presence in Europe and beyond. Esteve Healthcare is based in Barcelona, ES, and has subsidiaries in Germany. The company has launched an inhaled treatment for off periods in Parkinson's disease and is collaborating with Medtronic to improve the pathway of patients with refractory cancer pain. The company was founded in 1929 by Antoni Esteve Subirana, and Staffan Schüberg has been the CEO of the company since 2019.

Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain.

Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain.

Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain.

Esteve Healthcare SL is a Spanish international specialty pharma company that has experienced significant growth in 2022, expanding its presence in Europe and beyond. Esteve Healthcare is based in Barcelona, ES, and has subsidiaries in Germany. The company has launched an inhaled treatment for off periods in Parkinson's disease and is collaborating with Medtronic to improve the pathway of patients with refractory cancer pain. The company was founded in 1929 by Antoni Esteve Subirana, and Staffan Schüberg has been the CEO of the company since 2019.

Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain.

Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain.